Can a simple blood test warn of hormone Therapy's brain fog?
NCT ID NCT05820932
Summary
This study aims to see if a simple blood test can predict which prostate cancer patients will experience memory and thinking problems when they start hormone therapy (ADT). Researchers will follow 32 men to check if changes in a specific blood protein are linked to cognitive decline. The goal is to better understand this side effect to help patients and doctors make more informed treatment decisions.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of California, San Francisco
San Francisco, California, 94143, United States
Conditions
Explore the condition pages connected to this study.